Concomitant unilateral internal iliac artery embolization and endovascular infrarenal aortic aneurysm repair  by Lee, Chong et al.
Concomitant unilateral internal iliac artery
embolization and endovascular infrarenal
aortic aneurysm repair
Chong Lee, MD, Matthew Dougherty, MD, and Keith Calligaro, MD, Philadelphia, Penn
Introduction: Endograft limb extension to the external iliac artery with embolization of an internal iliac artery (IIA) may
be necessary in patients with abdominal aortic aneurysms (AAAs) extending to the common iliac artery to prevent
endoleak during endovascular aortic aneurysm repair (EVAR). Coil embolization of the IIA can be performed at the same
operative setting as EVAR or, alternatively, as a staged procedure. Most interventionalists favor the latter approach to
avoid excessive contrast material and prolonged operative time. We investigated the clinical outcome of concomitant vs
staged unilateral IIA embolization in the setting of EVAR.
Methods: Vascular surgeons at our institution treated 24 patients with infrarenal EVAR and unilateral coil embolization
of the IIA from October 1, 2000 to June 30, 2005. All patients had normal renal function. The details of the operative
procedure and perioperative complications were compared in patients undergoing concomitant vs staged procedures.
Follow up was 1 to 40 months (average, 11 months).
Results: Among the 24, 16 underwent concomitant unilateral IIA embolization in the setting of EVAR and eight patients
underwent the staged procedure. Average duration of operative time (298 vs 284 minutes), amount of intravenous
contrast (215mL vs 164mL), and preoperative (1.12 vs 1.26mg/dL), and postoperative (1.15 v. 1.31mg/dl) creatinine
levels were similar in the concomitant vs staged group, respectively (P > .05 for all factors). More sensitive markers of
renal insufficiency such as creatinine clearance were not measured. In the concomitant group, 25% (4/16) of patients
reported significant symptoms of buttock claudication ipsilateral to the embolized IIA, which resolved after a mean of 8.8
months (range, 1 to15 months) vs no cases (0/8) in the staged group (P  .02048). One patient in the staged group
developed ischemic colitis, which was treated conservatively. Coil embolizations that were performed as staged proce-
dures were all done on an outpatient basis. All 24 patients were admitted the day of the EVAR and were discharged the
next day, except one patient in the concomitant group was discharged the second day after the procedure, and one patient
in the staged group was discharged 7 days after the procedure.
Conclusion:Despite concern of prolonged operative time and the amount of contrast needed to perform concomitant IIA
embolization and EVAR, our results showed that in patients with normal renal function, concomitant unilateral IIA
embolization in the setting of EVAR was safe and effective and associated with shorter hospitalization compared with
staged procedures. The disadvantage of a concomitant procedure is an increased likelihood of transient buttock
claudication, but the small number of patients in this series prohibits definite conclusions about this complication. The
concomitant procedure may be preferable for infirm patients with normal renal function who would be greatly
inconvenienced by two procedures. ( J Vasc Surg 2006;43:903-7.)Endovascular abdominal aortic aneurysm repair
(EVAR) has gained increasingly widespread application to
treat abdominal aortic aneurysmal disease. It has been
shown to be a safe and effective procedure compared with
open aortic repair and an acceptable alternative in patients
with prohibitive surgical risks. Standard insertion of a bi-
furcated endograft requires an appropriate distal graft-
anchoring zone in the common iliac artery. However, an
estimated 20% to 30% of patients with an abdominal aortic
aneurysm (AAA) have concomitant iliac aneurysmal dis-
ease1,2 and lack the distal graft-anchoring zone for a safe
endograft deployment. In these cases, the ipsilateral inter-
nal iliac artery (IIA) can be embolized to cause thrombosis
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doi:10.1016/j.jvs.2005.12.063of the vessel and prevent retrograde flow into the aneurysm
before the placement of the bifurcated graft limb into the
external iliac artery.2-4
Coil embolization of the IIA can be performed at the
same operative setting as EVAR or, alternatively, as a staged
procedure.Most interventionalists favor the latter approach
to avoid excessive use of intravenous contrast and pro-
longed operative time. Concurrent IIA embolization with
EVAR may offer advantages, however, including enhanced
patient convenience by performing both procedures during
the same hospital visit instead of requiring two visits and
avoidance of the risk, albeit small, associated with a second
procedure. We analyzed the clinical outcome of concomi-
tant vs staged unilateral IIA embolization in the setting of
EVAR at a single institution.
METHODS
Twenty-four patients underwent EVAR with IIA em-
bolization for infrarenal AAAs extending into the common
iliac arteries from October 1, 2000 to June 30, 2005 at
903
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went unilateral IIA embolization in the same operative
setting as EVAR were included in the concomitant group,
and patients who underwent embolization followed by
EVAR were included in the staged group. Patient charac-
teristics, clinical variables, and outcome were reviewed ret-
rospectively and compared between the two groups (Table
I). All patients in this series were specifically asked if new
symptoms of claudication developed after the procedure(s).
The concomitant approach was only considered in patients
with normal renal function. The decision whether to per-
form the procedures concomitantly or staged was made at
the surgeon’s discretion but was not due to any specific
patient characteristics.
Patients were seen during follow-up visits at 1, 6, and
12 months, and annually thereafter. Interim visits were
scheduled as clinically indicated. The follow-up period was
1 to 40 months (average, 11 months). Serum creatinine
concentrations were measured preoperatively and on the
first day after the endovascular procedure. Creatinine clear-
ance was not measured, although it might have some added
value in identifying small changes in renal function.
The preoperative assessment included a standard
contrast-enhanced spiral computed tomography (CT) scan
with images acquired at 3-mm intervals. Vascular surgeons
performed all EVAR and unilateral IIA embolization pro-
cedures in an endovascular operating room under fluoro-
scopic guidance (OEC 9800, General Electric, Salt Lake
City, Utah).
Selective catheterization of the internal iliac artery was
performed after percutaneous puncture of the common
femoral artery during staged procedures and after puncture
of the exposed artery during concomitant procedures. All
coil embolizations were initially attempted via a contralat-
eral femoral approach, but if catheterization of the internal
iliac artery was unsuccessful, the ipsilateral approach was
used. Helical Nester platinum-fiber coils (Cook, Bloom-
ington, Ind) were placed in the main trunk and branches of
the internal iliac artery in four patients during the initial
part of our experience and only in the main trunk in the
later patients. In many cases, contrast continued to initially
Table I. Demographic characteristics of patient
population of 24 patients treated with unilateral internal
iliac artery coil embolization and endovascular aneurysm
repair
Concomitant group
n  16 (%)
Staged group
n  8 (%)
Mean age (years) 74 72
Male 15 (94) 5 (62)
Smoking 12 (75) 6 (75)
Hypertension 14 (88) 7 (88)
Diabetes 2 (12) 0 (0)
COPD 3 (19) 2 (25)
COPD, Chronic obstructive pulmonary disease.
P  .05 for comparison of factors between the two groups.fill the treated internal iliac artery immediately after coilembolization, but the artery was found to be thrombosed
during follow-up in all cases.
RESULTS
Unilateral IIA coil embolization was performed on 24
(14%) of 175 patients who underwent EVAR procedures
during this time. Of these 24 patients, 16 underwent
concomitant unilateral IIA embolization during EVAR,
and eight patients had the staged procedure. All operations
were technically successful in excluding the IIA and insert-
ing the endograft as preoperatively intended. All coil em-
bolizations were performed by using a contralateral femoral
approach, except for two cases where an ipsilateral ap-
proach proved necessary.
No patients had symptoms of preoperative lower-
extremity claudication or mesenteric ischemia. Other de-
mographic characteristics between the concomitant and
staged group are summarized in Table I. The mean age was
similar in both groups (74 vs 72) and men predominated in
both groups (94% in the concomitant vs 62% in the staged
group). The incidence of hypertension, diabetes, smoking,
and chronic pulmonary obstructive disease were similar in
patients undergoing concomitant vs staged procedures
(Table I).
The operative time, amount of intravenous contrast
used, and perioperative creatinine levels were compared
between the groups (Table II). All patients had a normal
creatinine concentration preoperatively. The average dura-
tion of total operative time was 298 minutes in the con-
comitant group vs 284 minutes staged group (P  .348).
The amount of total intravenous contrast used in the two
groups did not differ significantly, although there was a
trend toward significantly higher amount of contrast in the
concomitant group (P  .055). In addition, there was no
statistically significant difference in preoperative and post-
operative creatinine levels in either the concomitant (P 
.784) or staged group (P  .412).
In the concomitant group, new symptoms of hip and
buttock claudication (ipsilateral to the side of their IIA
occlusion) developed in four (25%) of 16 patients com-
pared to none in the eight patients in the staged group (P
.02048). These symptoms spontaneously resolved after 1
to 15 months (mean, 8.8 months). In one other patient in
the concomitant group, atheroembolization to an ipsilat-
eral toe developed, which resolved spontaneously. No pa-
tients in the concomitant group developed bowel ischemia.
In the staged group, ischemic colitis developed in one
patient on postoperative day 2 after EVAR, manifested by
abdominal pain, diarrhea, and an elevated white blood cell
count, and confirmed by patchy ischemic changes visual-
ized by sigmoidoscopy. The patient was managed success-
fully with bowel rest, hydration, and broad-spectrum anti-
biotics.
Coil embolizations performed as staged procedures
were all done on an outpatient basis. All patients were
admitted the day of the EVAR and were discharged the
next day, except one patient in the concomitant group was
discharged the second day after the procedure and one
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procedure (patient with bowel ischemia).
DISCUSSION
Since the introduction of endovascular abdominal aor-
tic aneurysm repair (EVAR) in 1991, its development and
application have rapidly expanded.5 Initially, extension of
the AAA into the common iliac arteries was a major limita-
tion to accomplishing full exclusion of the aneurysm with
an endograft. This obstacle was overcome by several ad-
junctive techniques. Large common iliac arteries have been
treated with a “bell-bottom” technique to preserve the
IIA.6,7 Operative bypass and transposition or ligation of the
IIA has also been described in treating aortoiliac aneurysms
with endografts.8,9
Wyers et al10 described a technique of intentional IIA
coverage without concomitant coil embolization during
EVAR in selected patients. The decision to cover the IIA
without concomitant coil embolization was based on the
presence of adequate graft oversizing in the most distal 5
mm of the common iliac artery and the most proximal 15
mm of the external iliac artery. In 22 of 33 cases, the IIA
was covered without coil embolization, whereas 11 patients
with inadequate graft oversizing in the common iliac artery
had IIA coil embolization. They reported no endoleaks,
graft migrations, or aneurysm enlargements in either
group.10
Although their report of 11 patients treated with IIA
coil embolization was smaller than our series of 24 patients,
the results showed absence of endoleak due to retrograde
flow from the IIA in both series. Others prefer to routinely
perform concomitant or staged IIA coil embolization along
with extension of an endograft into the external iliac artery
to prevent potential reflux and endoleak.6,7,11-13
When IIA embolization is performed, the most fre-
quent complication is the development of buttock claudi-
cation. Although not clearly documented, a potential ad-
vantage of a staged procedure is that additional collaterals
may develop after coil embolization with IIA occlusion and
before placement of the endograft. The reported risk of
buttock claudication after IIA occlusion was 10% to
41%.7,12,14-16 Cynamon et al16 studied 32 patients who
had unilateral IIA occlusion in the setting of EVAR and
Table II. Comparison of operative time, intravenous cont
and staged groups
Concomitan
group (n  16
Operative time (min) 298 (200-402
Intravenous contrast (mL) 215 (130-200
Pre-op creatinine (mg/dL) 1.12 (.50-1.50
Post-op creatinine (mg/dL) 1.15 (.60-1.31
Data are presented as average (range).
*P  .223.
†P  .206.reported new-onset buttock claudication in 13 patients(41%) at a mean follow-up period of 18 months. Razavi et
al15 reported a 38% incidence of symptomatic pelvic isch-
emia at a mean follow-up of 35 months in 32 patients who
had either unilateral or bilateral IIA occlusion during
EVAR. The likelihood of developing claudication in these
reports was somewhat higher compared with the 17% inci-
dence of claudication in the 24 patients treated by both
staged and concomitant procedures in our series.
In addition to claudication, sacrificing the IIA has been
associated with other complications such as colon ischemia,
erectile dysfunction, paraplegia, and pelvic necrosis.13,17-19
Several authors have attempted to identify patients at high
risk of developing these complications as a result of IIA
embolization. Yano et al20 identified two unique preoper-
ative angiographic findings that predicted pelvic ischemia:
(1) 70% stenosis of the origin of the contralateral IIA or
non-opacification of three or more named IIA branches,
and (2) diseased or absent ascending deep femoral branches
ipsilateral to the side of the IIA occlusion.
Iliopoulos et al21 evaluated the pressure changes in the
pelvic circulation by clamping the IIA in patients undergo-
ing open aortic surgery. They demonstrated that ipsilateral
circumflex branches of external iliac and deep femoral
artery provide greater collateral circulation than the con-
tralateral patent IIA. They suggested that it is important to
preserve or reconstruct diseased vessels in the external iliac
and deep femoral system ipsilateral to an occluded IIA to
prevent the risk of pelvic ischemia.
Additional concerns for performing concomitant IIA
embolization during EVAR include a prolonged operative
time and possibly associated increased morbidity. The lack
of operative time difference between the two groups in our
study suggests that the concomitant procedure is not asso-
ciated with unduly prolonged anesthesia time. Conversely,
conscious sedation necessary for staged IIA embolization
followed by EVAR is avoided in concomitant procedures,
thereby reducing a very slight increased incidence of possi-
ble anesthetic-associated complications. Concomitant pro-
cedures at our institution were performed with epidural or
general anesthesia, and the staged procedures were per-
formed with local anesthesia and sedation for coil emboli-
zation followed 1 week or more later by EVAR using
and perioperative serum creatinine levels in concomitant
Staged group
(n  8) P
284 (180-395) .348
164 (125-192) .055
1.26 (.60-1.50)†
1.31 (.65-1.75)†rast
t
)
)
)
)*
)*epidural or general anesthesia.
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both groups was small, and our results certainly do not
prove that a concomitant procedure is as safe as a staged
procedure. There is a concern that for elderly patients, who
we are trying to not inconvenience by two separate proce-
dures, that one long operative procedure may be more
deleterious. It should also be noted that the embolization
part of a concomitant procedure was done with general or
regional anesthesia, not local, as it was with a staged ap-
proach.
Another major consideration with concomitant IIA
coiling and EVAR is the increased volume of intravenous
contrast given in one setting. Contrast-induced nephropa-
thy (CIN), defined as a transient increase in creatinine of
25% above the baseline, is a well-recognized complication
in some high-risk patients after angiographic proce-
dures.22,23 It is the third most common cause of hospital-
acquired renal failure in patients who were admitted to
medical and surgical services,24 and the associated mortality
was significantly higher when compared with patients who
did not develop CIN (34% vs 7%).25 Although CIN-
induced hemodialysis is rare in clinical practice, transient
increases in serum creatinine levels predict longer hospital
stays and worsening of long-term outcomes.22,26
Several risks factors have been reported in the develop-
ment of CIN. These include baseline renal impairment,
congestive heart failure, diabetes mellitus, increased doses
of contrast media, volume depletion, and concurrent use of
nephrotoxic drugs.28,29 McCullough et al27 demonstrated
that the overall risk of CIN is higher in diabetic patients
(20%) than in nondiabetic patients (13%). Lower osmolar-
ity contrast agents and lower contrast volume reduce the
risk of renal toxicity.30,31
The minimal volume of contrast required to avoid CIN
is debatable,31 but it is logical to limit the amount of
contrast used for any interventional procedure. On average,
an additional 51mL of intravenous contrast was used in the
concomitant group at the same time as EVAR. We found
no statistically significant difference in the preoperative and
postoperative serum creatinine levels measured on the first
postoperative day between both groups, suggesting that
the concomitant procedure is not associated with an in-
creased incidence of CIN. It should be noted that contrast-
induced nephropathy or nephrotoxicity would not neces-
sarily be reflected in a creatinine level checked on the first
postoperative day. We wish to emphasize that the concom-
itant strategy was used only in patients with normal renal
function, and the staged approach may be preferable in
patients with abnormal baseline renal function.
Although the point of this report was not an economic
analysis, an unjustified difference in reimbursement for the
interventionalist exists. One disadvantage of performing
concomitant IIA embolization at the time of EVAR is
decreased reimbursements compared with performing the
procedures in a staged manner. According to the Centers
for Medicare and Medicaid Services (CMS), reimburse-
ments for interventionalists reported at the conclusion of
this study (June 2005) were approximately $683 less forperforming coil embolization concomitantly with EVAR
than if performed first in a staged procedure. This may be a
disincentive for what is likely the more cost-effective ap-
proach.
CONCLUSIONS
Despite the concern of prolonged operative time and
the amount of contrast needed to perform concomitant IIA
embolization and EVAR, our study showed that concom-
itant unilateral IIA embolization is as safe and effective as a
staged technique in patients with normal renal function.
Although patients did not complete a questionnaire detail-
ing patient satisfaction, clearly, it is more convenient for the
patient to undergo both procedures concomitantly. How-
ever, careful and detailed discussions should be held with
patients noting that although concomitant IIA coil embo-
lization will avoid the need for a second procedure as
required in the staged strategy, the potential likelihood for
buttock claudication might be higher. For elderly high-risk
patients with limited ambulation, normal renal function,
and who are not likely to be greatly bothered by temporary
claudication, the concomitant approach may be preferable.
Ultimately, the choice of concomitant or staged approaches
should be left to the discretion of the surgeon on a case-
by-case basis.
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